文献リスト

1) Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008; 117: 2608-16

2) Seo Y, Ito H, Nakatani S, et al. The role of echocardiography in predicting responders to cardiac resynchronization therapy: Results from the Japan Cardiac Resynchronization therapy registry Trial (J-CRT). Circ J. 2011; 75: 1156-63

3) Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350: 2140-50

4) Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352: 1539-49

5) Yu CM, Bleeker GB, Fung J, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resyn-chronization therapy. Circulation. 2005; 112: 1580-6

6) Ypenburg C, van Bommel RJ, Borleffs CJ, et al. Long-term prognosis after cardiac resynchro-nization therapy is related to the extent of left ven-tricular reverse remodeling at midterm follow-up. J Am Coll Cardiol. 2009; 53: 483-90

7) Cleland J, Freemantle N, Ghio S, et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. J Am Coll Cardiol. 2008; 52: 438-45

8) Ghio S, Freemantle N, Cleland JG, et al. Long-term ventricular reverse remodeling with cardiac resynchronization therapy. Results from the CARE-HF Trial. Eur J Heart Fail. 2009; 11: 480-8

9) Linde C, Abraham WT, Gold MR, et al; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resyn-chronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008; 52: 1834-43

10) Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009; 361: 1329-38

11) Solomon S, Foster E, Bourgoun M, et al. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: MADIT-CRT. Circulation. 2010; 122: 985-92

12) Pitzalis MV, Iacoviello M, Massari F, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol. 2002; 40: 1615-22

13) Yu CM, Fung JW, Zhang Q, et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and non-ischemic heart failure after cardiac resynchro-nization therapy. Circulation. 2004; 110: 66-73

14) Bax JJ, Marwick TH, Molhoek SG, et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol. 2003; 92: 1238-40

15) Cazeau S, Bordachar P, Jauvert G, et al. Echocardiographic modeling of cardiac dys-synchrony before and during multisite stimula-tion: a prospective study. Pacing Clin Electrophysiol. 2003; 26 (pt II): 137-43

16) Penicka M, Bartunek J, De Bruyne B, et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation. 2004; 109: 978-83

17) Abraham J, Abraham TP. Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization thera-py？ Echocardiography is useful before cardiac resynchronization therapy if QRS duration is available. Circ Cardiovasc Imaging. 2008; 1: 79-85

18) Prinzen FW, Auricchio A. Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization thera-py？ Echocardiography is not useful before car-diac resynchronization therapy if QRS duration is available. Circ Cardiovasc Imaging. 2008; 1: 70-8

19) Delgado V, Bax JJ. Assessment of systolic dyssynchrony for cardiac resynchronization therapy is clinically useful. Circulation. 2011; 123: 640-55

20) Sung RK, Foster E. Assessment of systolic dyssynchrony for cardiac resynchronization therapy is not clinically useful. Circulation. 2011; 123: 656-62

21) Suffoletto MS, Dohi K, Cannesson M, et al. Novel speckle tracking radial strain from routine black-and-white echocardiography images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation. 2006; 113: 960-8

22) Delgado V, Ypenburg C, Van Bommel RJ, et al. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol. 2008; 51: 1944-52

23) Gorcsan J III, Tanabe M, Bleeker GB, et al. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchro-nization therapy. J Am Coll Cardiol. 2007; 50: 1476-83

24) Lim P, Buakhamsri A, Popovic ZB, et al. Longitudinal strain delay index by speckle tracking imaging: a new marker of response to cardiac resynchronization therapy. Circulation. 2008; 118: 1130-7

25) Tanaka H, Nesser HJ, Buck T, et al. Dys-synchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Re-synchronization (STAR) study. Eur Heart J. 2010; 31: 1690-700

26) Seo Y, Ishizu T, Enomoto Y, et al. Validation of 3-dimensional speckle tracking imaging to quantify regional myocardial deformation. Circ Cardiovasc Imaging. 2009; 2: 451-9

27) Tanaka H, Hara H, Saba S, Gorcsan J III. Usefulness of three-dimensional speckle tracking strain to quantify dyssynchrony and the site of latest mechanical activation. Am J Cardiol. 2010; 105: 235-42

28) Yu CM, Chan YS, Zhang Q, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardio-graphy. J Am Coll Cardiol. 2006; 48: 2251-7

29) Bleeker GB, Holman ER, Steendijk P, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol. 2006; 48: 2243-50

30) Leon AR NI, Herrman K, Stucky M, et al. Chronic evaluation of CRT in narrow QRS patients with mechanical dyssynchrony from a multi-center study: ESTEEM-CRT. Heart Rhythm. 2008; 5: S23-S24

31) Beshai JF, Grimm RA, Nagueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007; 357: 2461-71

32) Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT). http://clinicaltrials.gov/ct2/show/NCT00683696

33) Bilchick KC, Dimaano V, Wu KC, et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2008; 1: 561-8

34) Westenberg JJ, Lamb HJ, van der Geest RJ, et al. Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy: head-to-head comparison between tissue Doppler imaging and velocity-encoded magnetic resonance imaging. J Am Coll Cardiol. 2006; 47: 2042-8

35) Marsan NA, Westenberg JJ, Ypenburg C, et al. Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue. Eur Heart J. 2009; 30: 2360-7

36) Leyva F, Foley PW, Stegemann B, et al. Development and validation of aclinical index to predict survival after cardiac resynchronisation therapy. Heart. 2009; 95: 1619-25

37) Mitka M. First MRI-safe pacemaker receives conditional approval from FDA. JAMA. 2011; 305: 985-6

38) Ypenburg C, van Bommel RJ, Delgado V, et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol. 2008; 52: 1402-9

39) Giraldi F, Cattadori G, Roberto M, et al. Long-term effectiveness of cardiac resynchronization therapy in heart failure patients with unfavorable cardiac veins anatomy comparison of surgical versus hemodynamic procedure. J Am Coll Cardiol. 2011; 58: 483-90

40) Singh JP, Houser S, Heist EK, Ruskin JN. The coronary venous anatomy: a segmental approach to aid cardiac resynchronization therapy. J Am Coll Cardiol. 2005; 46: 68-74

41) Jongbloed M, Lamb HJ, Bax J, et al. Noninvasive visualization of the cardiac venous system using multislice computed tomography. J Am Coll Cardiol. 2005; 45: 749-53

42) Di Biase L, Auricchio A, Mohanty P, et al. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace. 2011; 13: 829-38

43) Arshad A, Moss AJ, Foster E, et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multi-center Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol 2011; 57: 813-20

44) Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011; 123: 1061-72

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp